LV-ALIACIN
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80092050
- Status
- Inactive licence
- Licence date
- 3 May 2019
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Allium sativum Source : Bulbe Potency : 4,000 microgrammes Allicin | 700 milligramme | Not calculated |
Non-medicinal ingredients
Citrate de triéthyle, Bicarbonate de sodium, Cellulose microcristalline, Stéarate de magnésium, Hypromellose, Dioxyde de silicium, Hydroxypropylcellulose, Talc, Lauryl sulfate de sodium, Copolymère d'acide méthacrylique, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve the symptoms associated with upper respiratory tract infections and catarrhal conditions (such as nasal congestion/buildup of excess mucuous). Used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidaemia) in adults. Used in Herbal Medicine to help maintain cardiovascular health in adults. Used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidemia) and maintain cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs.
- Précautions et mises en garde
Consult a health care professional prior to use if you are taking blood thinners or protease inhibitors. Consult a health care professional prior to use if you are pregnant or have diabetes. For relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions: Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 80092050
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.